Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

NAZA - Nottingham/Astra ZenecA Prospective IBD Cohort Study

NCT06956703 is registered in ClinicalTrials.gov with University of Nottingham as lead sponsor.

NCT NCT06956703
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06956703 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
NAZA - Nottingham/Astra ZenecA Prospective IBD Cohort Study
Lead sponsor
University of Nottingham
Phase
Observational
Overall status
Recruiting
Start date
December 12, 2022
Completion date
December 31, 2027
Enrollment
240 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

crohn disease, gastro-intestinal disorder, inflammatory bowel diseases, ulcerative colitis